StockData
NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31

Ingevity Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$70.31+0.49 (+0.70%)

Close on Oct 19, 2026

Market cap
$2.48B
P/E (TTM)
47.8
Dividend yield
–

Earnings

Next report expected Nov 4, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 29, 2026After market close$314.10M$1.13$1.74
Q1 FY2026
Ended Mar 31, 2026
May 6, 2026After market close$258.00M$0.65$1.15
Q4 FY2025
Ended Dec 31, 2025
Feb 25, 2026After market close$255.10M$-2.21$0.58
Q3 FY2025
Ended Sep 30, 2025
Nov 5, 2025After market close$362.10M$1.18$1.52
Q2 FY2025
Ended Jun 30, 2025
Aug 4, 2025After market close$365.10M$-4.02$1.39
Q1 FY2025
Ended Mar 31, 2025
May 5, 2025After market close$284.00M$0.56$0.99
Q4 FY2024
Ended Dec 31, 2024
Jan 16, 2025Before market open–––
Q3 FY2024
Ended Sep 30, 2024
Oct 29, 2024After market close$376.90M$-2.95$1.10
Q2 FY2024
Ended Jun 30, 2024
Jul 31, 2024After market close–––
Q1 FY2024
Ended Mar 31, 2024
May 1, 2024After market close–––
Q4 FY2023
Ended Dec 31, 2023
Feb 21, 2024After market close–––

Company guidance

Outlook given with results on Jul 29, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
adjusted EBITDAnon-GAAPfull year 2026$380.00M to $400.00MRaised
diluted adjusted EPSnon-GAAPfull year 2026$5.00 to $5.45Raised
Free cash flownon-GAAPfull year 2026$220.00M to $245.00MRaised
net salesfull year 2026$1.05B to $1.15BMaintained

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Ingevity filed with the SEC